Chikungunya

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-06-22
Clinical Trial Update: Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and Asia [Phase 2, Phase 3]
A seamless Phase 2/3 trial evaluating the safety and immunogenicity of a chikungunya vaccine in Latin America and Asia has been terminated.